Recent studies also associate it with epithelial to mesenchymal transition (EMT), a biological phenomenon involved in the early progression of cancer metastasis, and the modulation of EMT regulators like Vimentin, Claudin-1 and other transcription factors, playing a dual role in EMT. The gene discussed is CLDN1; the disease is cancer.